News

Video

Treatment Strategies for Non-Clear Cell Renal Cell Carcinoma

Author(s):

Ulka Vaishampayan, MD,Alan Tan, MD

Expert panelists review the management of non-clear cell histology in renal cell carcinoma, exploring treatment options, clinical trials, and the potential role of immune checkpoint inhibitors.

Related Videos
Ami Umesh Badami, MD, medical oncologist, Endeavor Health Medical Group
Thomas Westbrook, MD, assistant professor, Department of Internal Medicine, Rush University
4 experts are featured in this series.
Related Content
Bradley McGregor, MD
January 15th 2025

Nivolumab Plus Ipilimumab May Offer Efficacious Therapeutic Approach in Rare GU Cancers

Oncology Unplugged
November 6th 2024

Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD

Yousef Zakharia, MD
January 14th 2025

Selecting Checkpoint Inhibitor–Based Regimens in Clear Cell RCC Requires Several Considerations

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

lertsakwiman – stock.adobe.com
January 8th 2025

China’s NMPA Approves Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Cancer

Toni Choueiri, MD
January 8th 2025

TiNivo-2 Data Underscore Challenges With ICI Retreatment in Advanced RCC